Results 101 to 110 of about 149 (148)

Multi‐microRNA diagnostic panel for heart failure with preserved ejection fraction in preclinical and clinical settings

ESC Heart Failure, EarlyView.
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) is a complex syndrome accounting for half of heart failure cases. Although natriuretic peptides are the most accepted and extensively used biomarkers for heart failure, their diagnostic accuracy for HFpEF remains debatable.
Reza Parvan, Natale Rolim, Andreas B. Gevaert, Alessandro Cataliotti, Emeline M. van Craenenbroeck, Volker Adams, Ulrik Wisløff, Gustavo Jose Justo Silva, on behalf of the OptimEx Study Group   +8 more
wiley   +1 more source

Left ventricular decompression in paediatric veno‐arterial extracorporeal life support: Reviewing the evidence

ESC Heart Failure, EarlyView.
Abstract Veno‐arterial extracorporeal life support (VA ECLS) is crucial for neonatal and paediatric patients with severe circulatory collapse but may cause left ventricular (LV) overload, affecting myocardial recovery and causing complications. Evidence on optimal LV decompression strategies in paediatric patients remains limited.
Giacomo Veronese, Paolo Meani, Domenico Sirico, Giovanni Di Salvo, Enrico Ammirati, Alessandro Varrica, Umberto Di Dedda, Paolo Bianchi, Giuseppe Isgrò, Alessandro Giamberti, Tommaso Aloisio, Marc Dickstein, Ezio Bonanomi, Bahaaldin Alsoufi, Ravi R. Thiagarajan, Peta M.A. Alexander, D. Michael McMullan, Ryan P. Barbaro, Graeme MacLaren, Marco Ranucci, Navin K. Kapur, Roberto Lorusso   +21 more
wiley   +1 more source

Association between NT‐proBNP changes and clinical outcomes in paediatric patients with heart failure: Insights from PANORAMA‐HF and PARADIGM‐HF

ESC Heart Failure, EarlyView.
This post hoc analysis of the PANORAMA‐HF paediatric heart failure trial evaluates the correlation of baseline and clinical changes in NT‐proBNP and clinical outcomes in children with heart failure due to left ventricular systolic dysfunction. This is the first prospective, randomized large‐scale study to demonstrate that changes in NT‐proBNP levels ...
Robert Shaddy, Jianjian Gong, Tania Garito, Susan Solar‐Yohay, Sijia Zhang, Margaret F. Prescott, Damien Bonnet, Paul F. Kantor, Michael Burch, Chad Mao, Antoinette Cilliers, Charles Canter, Yuk Law, Giorgia Grutter, Jou Kou Wang, Aamir Jeewa, Joseph Rossano, on behalf of PANORAMA‐HF investigators   +17 more
wiley   +1 more source

Quality of life after transcatheter tricuspid valve repair: results from the Tri.FR trial

ESC Heart Failure, EarlyView.
This study is one of the first randomised trials to demonstrate that transcatheter tricuspid valve repair (T‐TEER) yields substantial and sustained improvements in quality of life across multiple domains, beyond clinical and echocardiographic outcomes.
Sabina Istratoaie, Pascal de Groote, Nicole Karam, Jean‐Noel Trochu, Guillaume Leurent, Augustin Coisne, Pierre‐Yves Le Roux, Anne Ganivet, Anne Bernard, Antoinette Neylon, Romain Pierrard, Florent Le Ven, François Picard, Nicolas Piriou, Thierry Laperche, Jerome Jouan, Amedeo Anselmi, Vincent Auffret, Emmanuel Oger, Erwan Donal   +19 more
wiley   +1 more source

Short report: Hospitalization for new‐onset heart failure in survivors of hospitalized COVID‐19

ESC Heart Failure, EarlyView.
Abstract Aims Previous studies have reported an incidence of new‐onset heart failure (HF) among COVID‐19 survivors ranging from 0.7 to 8.5 per 100 person‐years, but they relied on administrative data for outcome ascertainment. Given the public health implications, a more accurate characterization of the HF burden post‐COVID‐19 is important. Methods and
Vicente Corrales‐Medina, Jordana B. Cohen, Seavmeiyin Kun, Bianca Pourmussa, Ozgun Erten, Joe‐David Azzo, Julio A. Chirinos   +6 more
wiley   +1 more source

Sex differences in the association between nutritional status and in‐hospital mortality in HFpEF patients

ESC Heart Failure, EarlyView.
Abstract Aims The study aimed to assess whether the effect of nutritional risk score (NRS‐2002) on the odds of in‐hospital mortality would be modulated by sex and body mass index (BMI) in patients with heart failure with preserved ejection fraction (HFpEF).
Michał Czapla, Adrian Kwaśny, Izabella Uchmanowicz, Łukasz Pietrzykowski, Christopher S. Lee, Wojciech Kosowski, Stanisław Surma, Halina Grajeta, Łukasz Lewandowski   +8 more
wiley   +1 more source

Implementation of guidelines for intravenous iron therapy in heart failure patients

ESC Heart Failure, EarlyView.
Abstract Aims We aim to evaluate the implementation of the 2021 ESC Guidelines regarding screening and treatment of iron deficiency in patients with heart failure (HF) at Karolinska University Hospital. Methods and results Patients with left ventricular ejection fraction (LVEF) < 50% and New York Heart Association (NYHA) class II–IV who visited ...
Milou Gamage, Aristomenis Manouras, Camilla Hage, Gianluigi Savarese, Karin Ljung, Michael Melin   +5 more
wiley   +1 more source

Proteins associated with rehospitalization, mortality and diuretic resistance in acutely decompensated heart failure

ESC Heart Failure, EarlyView.
Abstract Aims Most proteomic analyses in patients with heart failure (HF) focus on the stable ambulatory setting; pathways that drive acute decompensated heart failure (ADHF) are largely uncharacterized. We aimed to examine the associations of cardiometabolic proteins with HF rehospitalization, mortality and diuretic response in patients with ADHF ...
Kenneth T. Hubbell, Veena S. Rao, Rebecca Scherzer, Michael G. Shlipak, Juan B. Ivery‐Miranda, Nisha Bansal, Zachary L. Cox, Jeffrey M. Testani, Michelle M. Estrella   +8 more
wiley   +1 more source

Interconnected pathways and emerging therapies in chronic kidney disease and heart failure: A comprehensive review

ESC Heart Failure, EarlyView.
Abstract Chronic kidney disease (CKD) and chronic heart failure (HF) frequently coexist and, when comorbid, are associated with poorer outcomes. These two diseases have common risk factors, such as diabetes, obesity and hypertension, and common pathophysiological connected mechanisms, including inflammation, endothelial dysfunction, neurohormonal ...
Johann Bauersachs, Eri Toda Kato, Janani Rangaswami   +2 more
wiley   +1 more source

Identification, characterisation and outcomes of pre‐atrial fibrillation in heart failure with reduced ejection fraction

ESC Heart Failure, EarlyView.
Abstract Aims Atrial fibrillation (AF) in heart failure with reduced ejection fraction (HFrEF) has prognostic implications. Using a machine learning algorithm (FIND‐AF), we aimed to explore clinical events and the cardiac magnetic resonance (CMR) characteristics of the pre‐AF phenotype in HFrEF.
Anna Helbitz, Ramesh Nadarajah, Lan Mu, Harriet Larvin, Hesham Ismail, Ali Wahab, Patrick Thompson, Peter Harrison, Mohammad Harris, Tobin Joseph, Sven Plein, Mark Petrie, Marco Metra, Jianhua Wu, Peter Swoboda, Chris P. Gale   +15 more
wiley   +1 more source